Autori: Davies Andrew J
Naslov | Longer Term Efficacy and Safety of Subcutaneous Compared with Intravenous Rituximab: Updated Results of the Phase 3 SABRINA Study (Meeting Abstract) |
Autori | Davies Andrew J Mihaljevic Biljana S ![]() |
Info | BLOOD, (2016), vol. 128 br. 22, str. - |
Projekat | Takeda Pharmaceutical Company Ltd; |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Pharmacokinetics (PK), Safety and Overall Response Rate (ORR) Achieved with Subcutaneous (SC) Administration of Rituximab in Combination with Chemotherapy Were Comparable to Those Achieved with Intravenous (IV) Administration in Patients (pts) with Follicular Lymphoma (FL) in the First-Line Setting: Stage 1 Results of the Phase III SABRINA Study (BO22334) (Meeting Abstract) |
Autori | Davies Andrew J Merli Francesco Mihaljevic Biljana S ![]() |
Info | BLOOD, (2012), vol. 120 br. 21, str. - |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|